Join the club for FREE to access the whole archive and other member benefits.

Memorial Sloan Kettering Cancer Center

Cancer treatment and research institution in New York City

Memorial Sloan Kettering Cancer Center is a cancer treatment and research institution in New York City, founded in 1884 as the New York Cancer Hospital. MSKCC is the largest and oldest private cancer center in the world, and is one of 70 National Cancer Institute–designated Comprehensive Cancer Centers.

Visit website: https://www.mskcc.org/

 memorial-sloan-kettering-cancer-center

 sloan_kettering

 UC7CfDrRVN3yMVq7gq17hZdQ

Details last updated 05-May-2020

People at Memorial Sloan Kettering Cancer Center

Michael Overholtzer

Cell biologist & PhD holder from Princeton university who studies about tumors and cell death

Pedram Razavi

Medical Oncologist at Memorial Sloan Kettering Cancer Center.

Josef Leibold

Postdoctoral Researcher at Memorial Sloan Kettering Cancer Center

Michel Sadelain

Immunologist and director at Center for Cell Engineering

Scott Lowe

Cancer biologist and chair of cancer biology & genetics program at Memorial Sloan Kettering Cancer Center in US

Jonathan Peled

Medical oncologist, Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center News

New immune cells can recognise and eliminate a specific protein on ageing cells

New immune cells can recognise and eliminate a specific protein on ageing cells

Live Forever Club - 25-Jan-2024

In mice, this therapy was shown to reduce the number of senescent cells

New missile-like radioactive therapy treats prostate cancer

New missile-like radioactive therapy treats prostate cancer

The Institute of Cancer Research (ICR) - 03-Jun-2021

Precisely targeted therapy shrank tumours and extends life by 38% in men

Immunotherapy as new approach to battle senescent cells

Immunotherapy as new approach to battle senescent cells

Lifespan.io (LEAF) - 23-Jun-2020

Successful in mice, it may help treat many age-related disease in human

Genetically engineered T cells can be used to target and kill senescent cells

Genetically engineered T cells can be used to target and kill senescent cells

Medical Xpress - 17-Jun-2020

Tested successfully in mice with liver fibrosis and lung cancer